International Nuclear Information System

International Isotopes Inc. Announces It Has Acquired Full Ownership Of RadQual LLC

Retrieved on: 
Monday, July 12, 2021
Medicine, Neuroimaging, Medical physics, Medicinal radiochemistry, Medical specialties, Clinical medicine, Radiobiology, International Nuclear Information System, International Atomic Energy Agency, Single-photon emission computed tomography, iNiS, Nuclear medicine

In August 2017, this group of sellers acquired all of the units of RadQual not already held by INIS.

Key Points: 
  • In August 2017, this group of sellers acquired all of the units of RadQual not already held by INIS.
  • With this most recent acquisition, INIS will now own 100% of all outstanding units of RadQual, making RadQual a wholly-owned subsidiary of INIS.
  • RadQual is the premier global developer of quality control products for the nuclear medicine industry, focused principally on SPECT and PET imaging.
  • From RadQual 's inception in 2001, INIS has been the sole contract manufacturer of all RadQual products.

International Isotopes Inc. Comments On The Unusual Trading Volume And Share Price Volatility In Its Common Stock

Retrieved on: 
Thursday, January 21, 2021
OTC Markets Group, IDAHO, International Nuclear Information System, Isotope, United States

IDAHO FALLS, Idaho, Jan. 21, 2021 /PRNewswire/ -- International Isotopes Inc. (OTCQB: INIS) (the "Company"), due to recent unusual trading volume, and share price volatility in its common stock, is providing the following update on its business segments.

Key Points: 
  • IDAHO FALLS, Idaho, Jan. 21, 2021 /PRNewswire/ -- International Isotopes Inc. (OTCQB: INIS) (the "Company"), due to recent unusual trading volume, and share price volatility in its common stock, is providing the following update on its business segments.
  • These sales had been interrupted and the Company forced to secure alternate supplies for more than five years.
  • The Company is currently developing a business plan to produce additional radiopharmaceutical products or explore new contract manufacturing opportunities in this facility.
  • Currently, International Isotopes owns 25% of RadQual, and handles the manufacturing and distribution of RadQual products.

International Isotopes Inc. is Pleased to Announce the Addition of Dr. James R. Miles, to our Drug Product Manufacturing Team

Retrieved on: 
Monday, June 15, 2020
Chemistry, Physical sciences, Natural sciences, Iodides, Metal halides, Isotopes of iodine, Sodium iodide, Iodine-131, IDAHO, iNiS, Iodine, International Nuclear Information System

IDAHO FALLS, Idaho, June 15, 2020 /PRNewswire/ --International Isotopes Inc. (OTCQB: INIS) (the "Company") is pleased to announce it has hired Dr. James R. Miles, PharmD., ANP as its new Radiopharmaceutical Production Manager.

Key Points: 
  • IDAHO FALLS, Idaho, June 15, 2020 /PRNewswire/ --International Isotopes Inc. (OTCQB: INIS) (the "Company") is pleased to announce it has hired Dr. James R. Miles, PharmD., ANP as its new Radiopharmaceutical Production Manager.
  • Miles will be overseeing the production of our I-131 sodium iodide product and our contract manufacturing operations for Progenics Pharmaceuticals Inc.
    Dr.
  • Miles brings over 20 years of pharmacy and new product development experience to the INIS team.
  • Miles are a perfect fit for the Company and we are very pleased to have him join the INIS team.